Inhibition, by 2‐Oxo Acids That Accumulate in Maple‐Syrup‐Urine Disease, of Lactate, Pyruvate, and 3‐Hydroxybutyrate Transport Across the Blood‐Brain Barrier
Inhibition, by 2‐Oxo Acids That Accumulate in Maple‐Syrup‐Urine Disease, of Lactate, Pyruvate, and 3‐Hydroxybutyrate Transport Across the Blood‐Brain Barrier
复制标题
枫糖浆尿病中积累的 2-含氧酸抑制乳酸、丙酮酸和 3-羟基丁酸跨血脑屏障的转运
DOI:
--
复制
发表时间:
1982
影响因子:
4.7
通讯作者:
V. Cunningham
中科院分区:
文献类型:
--
作者:
J. E. Cremer;H. M. Teal;V. Cunningham
Abstract: Data are presented in support of the transport of (‐)‐d‐3‐hydroxybutyrate across the blood‐brain barrier (BBB) being a carrier‐mediated process. The kinetic parameters in 21‐day‐old pentobarbital‐anaesthetized rats were Vmax 2.0 μmol.g−1.min−1, Km 29 mM, and KD 0.024 ml.g−1.min−1. The value for Vmax was the same as that for l‐lactate and pyruvate transport in animals of the same age. The transport of all three substrates was sensitive to inhibition by low concentrations of either 2‐oxo‐3‐methylbutanoate or 2‐0x0‐4‐methylpentanoate, the 2‐oxo acids that can accumulate in patients with maple‐syrup‐urine disease. The Km values for the 2‐oxo acids were severalfold lower than the respective Km values. 2‐oxo‐3‐phenylpropionate was a poor inhibitor. The relative affinities of the various monocarboxylic acids for the transport system of the BBB distinguished it from similar systems described in brain, heart, and liver mitochondria; human erythrocytes; and Ehrlich ascites‐tumour cells.